Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Recurrence 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Large B-Cell, Diffuse 3Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell 2Multiple Myeloma 1Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 14fludarabine 8Rituximab 6Specimen Handling 5Magnetic Resonance Spectroscopy 5Vincristine 4Doxorubicin 4Dexamethasone 4zanubrutinib 3Prednisone 3Nivolumab 3Etoposide 3tazemetostat 2tafasitamab 2pirtobrutinib 2pembrolizumab 2glofitamab 2etoposide phosphate 2cemiplimab 2acalabrutinib 2Leukapheresis 2Immunotherapy, Adoptive 2Immunoglobulin G 2Gemcitabine 2Disulfides 2Cisplatin 2Cell- and Tissue-Based Therapy 2Biopsy 2venetoclax 1varlilumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, B-Cell × Immunotherapy, Adoptive × 30 days × Clear all
NCT05312476 2026-06-03

Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma

The First Affiliated Hospital of Soochow University

Phase 2 Withdrawn
Lymphoid

Lymphoma, B-Cell

NCT07584889 2026-05-13

CAR-p40-T

Shenzhen University General Hospital

Phase 1/2 Recruiting
10 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡